CliffBio
small molecule

POTASSIUM ACETATE

POTASSIUM ACETATE

Loss of exclusivity—loss of exclusivity
CompanyExela Pharma Sciences Llc →See this company's full patent-cliff portfolio

Drug detail

Brand namePOTASSIUM ACETATE
Active ingredientPOTASSIUM ACETATE
Strength2MEQ/ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalOctober 2021
Marketing statusRX

More from Exela Pharma Sciences Llc

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

POTASSIUM ACETATE patent cliff — loss of exclusivity — | CliffBio